A-366 |
Purity >98%. A-366 is a potent and selective G9a / GLP histone lysine meth… |
10 mg, 25 mg, 50 mg |
MBS384085 |
More Info
|
A427 |
A427 cells are derived from human lung epithelial carcinoma taken from a 5… |
0.1 mg, 0.2 mg, 0.5 mg |
MBS201043 |
More Info
|
A431 |
A431 cells were established from an epidermoid carcinoma in the skin / epi… |
0.1 mg, 0.2 mg, 0.5 mg |
MBS201022 |
More Info
|
A-443654 |
Purity >98%. A-443654, a specific Akt inhibitor with Ki value of 160 pM, i… |
2 mg, 5 mg, 10 mg |
MBS384086 |
More Info
|
A-484954 |
Purity >98%. A-484954 is a potent, selective inhibitor of eukaryotic longa… |
10 mg, 25 mg, 50 mg |
MBS384087 |
More Info
|
A549 |
A549 cells are adenocarcinomic human alveolar basal epithelial cells. The… |
0.1 mg, 0.2 mg, 0.5 mg |
MBS201023 |
More Info
|
A66 |
MW: 393.53 |
10 mg |
MBS8506193 |
More Info
|
A66 |
Purity >98%. The S-enantiomer of A66 is a potent inhibitor of the p110alph… |
5 mg, 1 mL (in DMSO), 10 mg |
MBS384089 |
More Info
|
A66 |
Purity 97%+. MW: 393.53 |
2 mg, 5 mg, 1ml/10mM (in DMSO) |
MBS575616 |
More Info
|
A-674563 |
MW: 358.44 |
2 mg |
MBS8506244 |
More Info
|
A-674563 |
Purity ≥98%. A-674563 is an Akt1 inhibitor with Ki of 11 nM, modest pot… |
1 mg, 2 mg, 5 mg |
MBS578707 |
More Info
|
A-674563 |
Purity ≥98%. MW: 358.445 |
100 mg, 500 mg |
MBS131746 |
More Info
|
A-674563 |
Purity >98%. A-674563 is a B / Akt inhibitor with an IC50 of 14 nM and als… |
5 mg, 1 mL (in DMSO), 10 mg |
MBS384090 |
More Info
|
A-769662 |
Purity ≥98% by HPLC. Background: Cell-permeable. A potent AMPK activato… |
5 mg |
MBS842018 |
More Info
|
A-769662 |
Purity >98%. A-769662 is a new activator of AMP-activated protein kinase (… |
5 mg, 10 mg, 1 mL (in DMSO) |
MBS384092 |
More Info
|
A77 1726 |
Purity ≥98% by HPLC. Background: Physiologically active metabolite of t… |
5 mg, 25 mg |
MBS842963 |
More Info
|
A77-01 |
Purity ≥98%. MW: 286.33 |
2 mg, 5 mg, 1ml/10mM (in DMSO) |
MBS577536 |
More Info
|
A77-01 |
Purity ≥98%. MW: 286.338 |
100 mg, 500 mg |
MBS130865 |
More Info
|
A-803467 |
Purity ≥98% (TLC). MW: 357.8 |
10 mg, 50 mg |
MBS565381 |
More Info
|
A-803467 |
Purity ≥98% by TLC. Background: A-803467 is a potent, selective inhibit… |
5 mg, 25 mg |
MBS842200 |
More Info
|
A-803467 |
Purity ≥98%. MW: 357.79 |
100 mg, 500 mg |
MBS132100 |
More Info
|
A-803467 |
Purity ≥98%. MW: 357.79 |
1ml/10mM (in DMSO), 10 mg, 25 mg |
MBS575739 |
More Info
|
A-804598 |
Purity >98%. A-804598 is a P2X7 selective, competitive antagonist with the… |
5 mg, 10 mg, 25 mg |
MBS384094 |
More Info
|
A83-01 |
Purity >98% (TLC); NMR (Conforms). ALK inhibitor. Selective glycogen synth… |
5 mg, 25 mg |
MBS515040 |
More Info
|
A-83-01 |
Purity 97%+. MW: 421.52 |
2 mg, 5 mg, 10 mg |
MBS575483 |
More Info
|